参考文献/References:
[1] Biondi-Zoccai G,Moretti C,Abbate A,et al. Percutaneous coronary intervention for small vessel coronary artery disease[J]. Cardiovasc Revasc Med ,2010,11(3):189-198.
[2] Wybraniec MT,Bańka P,Bochenek T,et al. Small vessel coronary artery disease:how small can we go with myocardial revascularization?[J]. Cardiol J,2021,28(5):767-778.
[3] Jeger RV,Eccleshall S,Wan Ahmad WA,et al. Drug-coated balloons for coronaryartery disease:Third Report of the International?DCB?Consensus Group[J]. JACC Cardiovasc Interv,2020,13(12):1391-1402.
[4] Venetsanos D,Lawesson SS,Panayi G,et al. Long-term efficacy of drug coated balloons compared with new generation drug-eluting stents for the treatment of de novo coronary artery lesions[J]. Catheter Cardiovasc Interv,2018,92(5):E317-e326.
[5] Giannini F,Khokhar AA,Albani S. Percutaneous intervention in small-vessel coronary disease:time to clear the fog?[J]. JACC Cardiovasc Interv,2020,13(7):805-807.
[6] Ono M,Kawashima H,Hara H,et al. A prospective multicenter randomized trial to assess the effectiveness of the MagicTouch sirolimus-coated balloon in small vessels:rationale and design of the TRANSFORMⅠtrial[J]. Cardiovasc Revasc Med,2021,25:29-35.
[7] El-Mokdad R,di Palma G,Cortese B. Long-term follow-up after sirolimus-coated balloon use for coronary artery disease. Final results of the Nanolutè study[J]. Catheter Cardiovasc Interv,2020,96(5):E496-E500.
[8] Latib A,Colombo A,Castriota F,et al. A randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels:the BELLO(Balloon Elution and Late Loss Optimization) study[J]. J Am Coll Cardiol,2012,60(24):2473-2480.
[9] Latib A,Ruparelia N,Menozzi A,et al. 3-Year Follow-Up of the Balloon Elution and Late Loss Optimization Study(BELLO)[J]. JACC Cardiovasc Interv,2015,8(8):1132-1134.
[10] Tang Y,Qiao S,Su X,et al. Drug-coated balloon versus drug-eluting stent for small-vessel disease:The RESTORE SVD China Randomized Trial[J]. JACC Cardiovasc Interv,2018,11(23):2381-2392.
[11] Cortese B,di Palma G,Guimaraes MG,et al. Drug-coated balloon versus drug-eluting stent for small coronary vessel disease:PICCOLETO Ⅱ Randomized Clinical Trial[J]. JACC Cardiovasc Interv ,2020,13(24):2840-2849.
[12] Jeger RV,Farah A,Ohlow MA,et al. Drug-coated balloons for small coronary artery disease(BASKET-SMALL 2):an open-label randomised non-inferiority trial[J]. Lancet,2018,392(10150):849-856.
[13] Jeger RV,Farah A,Ohlow MA,et al. Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease(BASKET-SMALL 2):3-year follow-up of a randomised,non-inferiority trial[J]. Lancet,2020,396(10261):1504-1510.
[14] Cortese B,Micheli A,Picchi A,et al. Paclitaxel-coated balloon versus drug-eluting stent during PCI of small coronary vessels,a prospective randomised clinical trial. The PICCOLETO study[J]. Heart,2010,96(16):1291-1296.
[15] Silverio A,Buccheri S,Venetsanos D,et al. Percutaneous treatment and outcomes of small coronary vessels:A SCAAR Report[J]. JACC Cardiovasc Interv,2020,13(7):793-804.
[16] Unverdorben M,Kleber FX,Heuer H,et al. Treatment of small coronary arteries with a paclitaxel-coated balloon catheter[J]. Clin Res Cardiol,2010,99(3):165-174.
[17] Hui L,Shin ES,Jun EJ,et al. Impact of dissection after drug-coated balloon treatment of de novo coronary lesions:angiographic and clinical outcomes[J]. Yonsei Med J,2020,61(12):1004-1012.
[18] Sinaga DA,Ho HH,Zeymer U,et al. Drug coated balloon angioplasty in elderly patients with small vessel coronary disease[J]. Ther Adv Cardiovasc Dis,2015,9(6):389-396.
[19] 谢江波,温燕华,衷涛,等. 药物涂层球囊在糖尿病患者冠状动脉小血管病变中的疗效分析[J]. 国际心血管病杂志,2019,46(5):297-300.
[20] Onishi T,Onishi Y,Kobayashi I,et al. Drug-coated balloon angioplasty for de novo small vessel disease including chronic total occlusion and bifurcation in real-world clinical practice[J]. Cardiovasc Interv Ther,2019,34 (2):139-148.
[21] 吴思靖,傅明洁,刘巍,等. 2018 ESC/EACTS心肌血运重建指南解读[J]. 中国循环杂志,2018,11(33):6-9.
[22] Mahmood Zuhdi AS,Zeymer U,Waliszewski M,et al. The use of paclitaxel coated balloon(PCB) in acute coronary syndrome of small vessel de novo lesions:an analysis of a prospective ‘real world’ registry[J]. Springerplus,2016,5:373.
[23] Abellas-Sequeiros RA,Benezet J,Agarrado Luna A,et al. Percutaneous coronary intervention for treating de-novo lesions in small coronary vessels:initial experience with the Essential paclitaxel-coated balloon[J]. Coron Artery Dis,2018,29(6):477-481.
[24] Yerasi C,Case BC,Forrestal BJ,et al. Drug-coated balloon for de novo coronary artery disease:JACC state-of-the-art review[J]. J Am Coll Cardiol,2020,75(9):1061-1073.
相似文献/References:
[1]何晨,综述,袁晋青,等.冠状动脉支架置入术后再狭窄的治疗研究进展[J].心血管病学进展,2016,(4):350.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.006]
HE Chen,YUAN Jinqing.Current Treatment of In-stent Restenosis[J].Advances in Cardiovascular Diseases,2016,(1):350.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.006]
[2]陆鑫 张华.无载体含药物洗脱支架研究进展1[J].心血管病学进展,2019,(7):1032.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.017]
LU xinZHANG Hua.Polymer-free Drug-eluting Stent[J].Advances in Cardiovascular Diseases,2019,(1):1032.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.017]
[3]陈彭辉 李军山 何晋.血管内超声指导冠状动脉复杂病变的介入治疗进展[J].心血管病学进展,2020,(11):1140.[doi:10.16806/j.cnki.issn.1004-3934.2020.11.000]
CHEN Penghui,LI Junshan,HE Jin.Interventional Therapy for Complex Coronary Artery Lesions Guided by Intravascular Ultrasound[J].Advances in Cardiovascular Diseases,2020,(1):1140.[doi:10.16806/j.cnki.issn.1004-3934.2020.11.000]
[4]刘文 魏芳晶.药物涂层球囊在真性分叉病变中的研究进展[J].心血管病学进展,2022,(6):511.[doi:10.16806/j.cnki.issn.1004-3934.2022.06.008]
LIU WenWEI Fangjing.Study of Drug-Coated?Balloon in?rue Coronary Bifurcation Lesions[J].Advances in Cardiovascular Diseases,2022,(1):511.[doi:10.16806/j.cnki.issn.1004-3934.2022.06.008]
[5]徐怡 农家聪 郭雅洁 许田 尤威 吴向起 吴志明 孟培娜 贾海波 叶飞.药物洗脱支架植入术后边缘效应的研究进展[J].心血管病学进展,2022,(12):1083.[doi:10.16806/j.cnki.issn.1004-3934.2022.12.006]
XU Yi,NONG Jiacong,GUO Yajie,et al.Edge Effect After Drug Eluting Stenting[J].Advances in Cardiovascular Diseases,2022,(1):1083.[doi:10.16806/j.cnki.issn.1004-3934.2022.12.006]
[6]周昌颐 王瑞 沈雳.血管支架植入对血管平滑肌细胞的影响[J].心血管病学进展,2023,(4):299.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.003]
ZHOU Changyi,WANG Rui,SHEN Li.Impact of Vascular Stent Implantation on Vascular Smooth Muscle Cells[J].Advances in Cardiovascular Diseases,2023,(1):299.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.003]
[7]菲尔凯提·玉山江 蒋学俊.药物涂层球囊在冠状动脉慢性完全闭塞病变介入治疗中的应用[J].心血管病学进展,2024,(1):62.[doi:10.16806/j.cnki.issn.1004-3934.2024.01.016]
Feierkaiti·Yushanjiang,JIANG Xuejun.The Application of Drug-Coated Balloon in the Intervention Treatment of Chronic Total Coronary Occlusion[J].Advances in Cardiovascular Diseases,2024,(1):62.[doi:10.16806/j.cnki.issn.1004-3934.2024.01.016]
[8]刘玉莹,杨斌.PCI术后损伤血管再内皮化延迟的机制与治疗研究综述[J].心血管病学进展,2024,(3):248.[doi:10.16806/j.cnki.issn.1004-3934.2024.03.013]
LIU Yuying,YANG Bin.A Review of the mechanism and therapy of delayed re-endothelialization of injured vessels after PCI[J].Advances in Cardiovascular Diseases,2024,(1):248.[doi:10.16806/j.cnki.issn.1004-3934.2024.03.013]
[9]赵代鑫?胡晓军?谭巨浪?裴畅.基于Meta分析对比药物涂层球囊与药物洗脱支架在细小冠状动脉疾病中的应用[J].心血管病学进展,2022,(1):82.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.021]
ZHAO Daixin,HU Xiaojun,TAN Julang,et al.Comparison of Application of Drug-Coated Balloon and Drug-Eluting Stent in Small Coronary Artery Disease Based on Meta Analysis[J].Advances in Cardiovascular Diseases,2022,(1):82.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.021]
[10]袁晓航 冯欢欢 高磊.复发性支架内再狭窄的研究进展[J].心血管病学进展,2022,(8):677.[doi:10.16806/j.cnki.issn.1004-3934.2022.08.002]
YUAN Xiaohang FENG Huanhuan GAO Lei.Recurrent In-Stent Restenosis[J].Advances in Cardiovascular Diseases,2022,(1):677.[doi:10.16806/j.cnki.issn.1004-3934.2022.08.002]